PDB Short entry for 1CXE HEADER GLYCOSYLTRANSFERASE 28-JUL-95 1CXE TITLE COMPLEX OF CGTASE WITH MALTOTETRAOSE AT ROOM TEMPERATURE AND PH 9.1 TITLE 2 BASED ON DIFFRACTION DATA OF A CRYSTAL SOAKED WITH ALPHA-CYCLODEXTRIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLODEXTRIN GLYCOSYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CGTASE; COMPND 5 EC: 2.4.1.19 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CIRCULANS; SOURCE 3 ORGANISM_TAXID: 1397; SOURCE 4 STRAIN: 251 KEYWDS GLYCOSYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR R.M.A.KNEGTEL,B.V.STROKOPYTOV,B.W.DIJKSTRA REVDAT 4 29-JUL-20 1CXE 1 COMPND REMARK HET HETNAM REVDAT 4 2 1 FORMUL LINK SITE ATOM REVDAT 3 18-APR-18 1CXE 1 REMARK REVDAT 2 24-FEB-09 1CXE 1 VERSN REVDAT 1 15-DEC-95 1CXE 0 JRNL AUTH R.M.KNEGTEL,B.STROKOPYTOV,D.PENNINGA,O.G.FABER,H.J.ROZEBOOM, JRNL AUTH 2 K.H.KALK,L.DIJKHUIZEN,B.W.DIJKSTRA JRNL TITL CRYSTALLOGRAPHIC STUDIES OF THE INTERACTION OF CYCLODEXTRIN JRNL TITL 2 GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 WITH JRNL TITL 3 NATURAL SUBSTRATES AND PRODUCTS. JRNL REF J.BIOL.CHEM. V. 270 29256 1995 JRNL REFN ISSN 0021-9258 JRNL PMID 7493956 JRNL DOI 10.1074/JBC.270.49.29256 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.STROKOPYTOV,D.PENNINGA,H.J.ROZEBOOM,K.H.KALK,L.DIJKHUIZEN, REMARK 1 AUTH 2 B.W.DIJKSTRA REMARK 1 TITL X-RAY STRUCTURE OF CYCLODEXTRIN GLYCOSYLTRANSFERASE REMARK 1 TITL 2 COMPLEXED WITH ACARBOSE. IMPLICATIONS FOR THE CATALYTIC REMARK 1 TITL 3 MECHANISM OF GLYCOSIDASES REMARK 1 REF BIOCHEMISTRY V. 34 2234 1995 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH C.L.L.LAWSON,R.VAN MONTFORT,B.STROKOPYTOV,H.J.ROZEBOOM, REMARK 1 AUTH 2 K.H.KALK,G.E.DE VRIES,D.PENNINGA,L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL NUCLEOTIDE SEQUENCE AND X-RAY STRUCTURE OF CYCLODEXTRIN REMARK 1 TITL 2 GLYCOSYLTRANSFERASE FROM BACILLUS CIRCULANS STRAIN 251 IN A REMARK 1 TITL 3 MALTOSE-DEPENDENT CRYSTAL FORM REMARK 1 REF J.MOL.BIOL. V. 236 590 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH C.L.L.LAWSON,J.BERGSMA,P.M.BRUINENBERG,G.DE VRIES, REMARK 1 AUTH 2 L.DIJKHUIZEN,B.W.DIJKSTRA REMARK 1 TITL MALTODEXTRIN-DEPENDENT CRYSTALLIZATION OF CYCLOMALTODEXTRIN REMARK 1 TITL 2 GLUCANOTRANSFERASE FROM BACILLUS CIRCULANS REMARK 1 REF J.MOL.BIOL. V. 214 807 1990 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 40003 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.153 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : 0.100 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 116 REMARK 3 SOLVENT ATOMS : 417 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.007 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 1.100 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : 17.500; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : 0.010 ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 2.180 ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : 0.018 ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CXE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172583. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-92 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 9.1 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : ENRAF-NONIUS FAST REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MADNES REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 1.220 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 9.1 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 60.69400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.19300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.80200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.19300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 60.69400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.80200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 25 -66.96 -96.84 REMARK 500 ALA A 96 35.13 -88.89 REMARK 500 TRP A 101 72.27 -111.52 REMARK 500 THR A 141 -84.73 -106.17 REMARK 500 ALA A 152 -128.56 49.95 REMARK 500 TYR A 195 -126.34 60.40 REMARK 500 ARG A 294 -64.85 -104.10 REMARK 500 ASN A 299 -169.66 -119.11 REMARK 500 PHE A 381 52.11 -118.08 REMARK 500 SER A 427 44.48 -95.87 REMARK 500 ASN A 627 26.05 -158.99 REMARK 500 VAL A 629 -79.26 -75.07 REMARK 500 PRO A 634 30.30 -86.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 689 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 27 OD1 REMARK 620 2 ASN A 29 O 80.5 REMARK 620 3 ASN A 32 OD1 146.1 66.3 REMARK 620 4 ASN A 33 OD1 90.5 89.6 95.7 REMARK 620 5 GLY A 51 O 71.9 151.9 140.1 95.1 REMARK 620 6 ASP A 53 OD2 79.8 78.4 86.7 165.6 91.9 REMARK 620 7 HOH A 780 O 141.4 136.6 72.5 81.4 71.4 112.7 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 690 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 139 OD1 REMARK 620 2 ILE A 190 O 157.1 REMARK 620 3 ASP A 199 OD1 77.1 115.7 REMARK 620 4 ASP A 199 OD2 123.4 76.9 51.0 REMARK 620 5 HIS A 233 O 76.1 83.5 143.2 160.4 REMARK 620 6 HOH A 698 O 69.0 130.9 76.2 77.2 116.0 REMARK 620 7 HOH A 709 O 93.9 73.3 73.9 92.0 83.3 148.2 REMARK 620 N 1 2 3 4 5 6 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: CA1 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: 1ST CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: CA2 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: 2ND CALCIUM BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 16 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: 1ST MALTOSE BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 26 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: 2ND MALTOSE BINDING SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: 36 REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: 3RD MALTOSE BINDING SITE, - DENOTES SYMMETRY REMARK 800 -RELATED MOLECULE. DBREF 1CXE A 1 686 UNP P43379 CDGU_BACCI 28 713 SEQRES 1 A 686 ALA PRO ASP THR SER VAL SER ASN LYS GLN ASN PHE SER SEQRES 2 A 686 THR ASP VAL ILE TYR GLN ILE PHE THR ASP ARG PHE SER SEQRES 3 A 686 ASP GLY ASN PRO ALA ASN ASN PRO THR GLY ALA ALA PHE SEQRES 4 A 686 ASP GLY THR CYS THR ASN LEU ARG LEU TYR CYS GLY GLY SEQRES 5 A 686 ASP TRP GLN GLY ILE ILE ASN LYS ILE ASN ASP GLY TYR SEQRES 6 A 686 LEU THR GLY MET GLY VAL THR ALA ILE TRP ILE SER GLN SEQRES 7 A 686 PRO VAL GLU ASN ILE TYR SER ILE ILE ASN TYR SER GLY SEQRES 8 A 686 VAL ASN ASN THR ALA TYR HIS GLY TYR TRP ALA ARG ASP SEQRES 9 A 686 PHE LYS LYS THR ASN PRO ALA TYR GLY THR ILE ALA ASP SEQRES 10 A 686 PHE GLN ASN LEU ILE ALA ALA ALA HIS ALA LYS ASN ILE SEQRES 11 A 686 LYS VAL ILE ILE ASP PHE ALA PRO ASN HIS THR SER PRO SEQRES 12 A 686 ALA SER SER ASP GLN PRO SER PHE ALA GLU ASN GLY ARG SEQRES 13 A 686 LEU TYR ASP ASN GLY THR LEU LEU GLY GLY TYR THR ASN SEQRES 14 A 686 ASP THR GLN ASN LEU PHE HIS HIS ASN GLY GLY THR ASP SEQRES 15 A 686 PHE SER THR THR GLU ASN GLY ILE TYR LYS ASN LEU TYR SEQRES 16 A 686 ASP LEU ALA ASP LEU ASN HIS ASN ASN SER THR VAL ASP SEQRES 17 A 686 VAL TYR LEU LYS ASP ALA ILE LYS MET TRP LEU ASP LEU SEQRES 18 A 686 GLY ILE ASP GLY ILE ARG MET ASP ALA VAL LYS HIS MET SEQRES 19 A 686 PRO PHE GLY TRP GLN LYS SER PHE MET ALA ALA VAL ASN SEQRES 20 A 686 ASN TYR LYS PRO VAL PHE THR PHE GLY GLU TRP PHE LEU SEQRES 21 A 686 GLY VAL ASN GLU VAL SER PRO GLU ASN HIS LYS PHE ALA SEQRES 22 A 686 ASN GLU SER GLY MET SER LEU LEU ASP PHE ARG PHE ALA SEQRES 23 A 686 GLN LYS VAL ARG GLN VAL PHE ARG ASP ASN THR ASP ASN SEQRES 24 A 686 MET TYR GLY LEU LYS ALA MET LEU GLU GLY SER ALA ALA SEQRES 25 A 686 ASP TYR ALA GLN VAL ASP ASP GLN VAL THR PHE ILE ASP SEQRES 26 A 686 ASN HIS ASP MET GLU ARG PHE HIS ALA SER ASN ALA ASN SEQRES 27 A 686 ARG ARG LYS LEU GLU GLN ALA LEU ALA PHE THR LEU THR SEQRES 28 A 686 SER ARG GLY VAL PRO ALA ILE TYR TYR GLY THR GLU GLN SEQRES 29 A 686 TYR MET SER GLY GLY THR ASP PRO ASP ASN ARG ALA ARG SEQRES 30 A 686 ILE PRO SER PHE SER THR SER THR THR ALA TYR GLN VAL SEQRES 31 A 686 ILE GLN LYS LEU ALA PRO LEU ARG LYS CYS ASN PRO ALA SEQRES 32 A 686 ILE ALA TYR GLY SER THR GLN GLU ARG TRP ILE ASN ASN SEQRES 33 A 686 ASP VAL LEU ILE TYR GLU ARG LYS PHE GLY SER ASN VAL SEQRES 34 A 686 ALA VAL VAL ALA VAL ASN ARG ASN LEU ASN ALA PRO ALA SEQRES 35 A 686 SER ILE SER GLY LEU VAL THR SER LEU PRO GLN GLY SER SEQRES 36 A 686 TYR ASN ASP VAL LEU GLY GLY LEU LEU ASN GLY ASN THR SEQRES 37 A 686 LEU SER VAL GLY SER GLY GLY ALA ALA SER ASN PHE THR SEQRES 38 A 686 LEU ALA ALA GLY GLY THR ALA VAL TRP GLN TYR THR ALA SEQRES 39 A 686 ALA THR ALA THR PRO THR ILE GLY HIS VAL GLY PRO MET SEQRES 40 A 686 MET ALA LYS PRO GLY VAL THR ILE THR ILE ASP GLY ARG SEQRES 41 A 686 GLY PHE GLY SER SER LYS GLY THR VAL TYR PHE GLY THR SEQRES 42 A 686 THR ALA VAL SER GLY ALA ASP ILE THR SER TRP GLU ASP SEQRES 43 A 686 THR GLN ILE LYS VAL LYS ILE PRO ALA VAL ALA GLY GLY SEQRES 44 A 686 ASN TYR ASN ILE LYS VAL ALA ASN ALA ALA GLY THR ALA SEQRES 45 A 686 SER ASN VAL TYR ASP ASN PHE GLU VAL LEU SER GLY ASP SEQRES 46 A 686 GLN VAL SER VAL ARG PHE VAL VAL ASN ASN ALA THR THR SEQRES 47 A 686 ALA LEU GLY GLN ASN VAL TYR LEU THR GLY SER VAL SER SEQRES 48 A 686 GLU LEU GLY ASN TRP ASP PRO ALA LYS ALA ILE GLY PRO SEQRES 49 A 686 MET TYR ASN GLN VAL VAL TYR GLN TYR PRO ASN TRP TYR SEQRES 50 A 686 TYR ASP VAL SER VAL PRO ALA GLY LYS THR ILE GLU PHE SEQRES 51 A 686 LYS PHE LEU LYS LYS GLN GLY SER THR VAL THR TRP GLU SEQRES 52 A 686 GLY GLY SER ASN HIS THR PHE THR ALA PRO SER SER GLY SEQRES 53 A 686 THR ALA THR ILE ASN VAL ASN TRP GLN PRO HET GLC B 1 12 HET GLC B 2 11 HET GLC B 3 11 HET GLC B 4 11 HET GLC C 1 12 HET GLC C 2 11 HET GLC D 1 12 HET GLC D 2 11 HET GLC E 1 12 HET GLC E 2 11 HET CA A 689 1 HET CA A 690 1 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION FORMUL 2 GLC 10(C6 H12 O6) FORMUL 6 CA 2(CA 2+) FORMUL 8 HOH *417(H2 O) HELIX 1 1 THR A 22 ARG A 24 5 3 HELIX 2 2 PRO A 30 ASN A 32 5 3 HELIX 3 3 GLY A 36 ALA A 38 5 3 HELIX 4 4 TRP A 54 ASN A 62 1 9 HELIX 5 5 TYR A 65 MET A 69 1 5 HELIX 6 6 ILE A 115 LYS A 128 1 14 HELIX 7 7 THR A 186 TYR A 191 1 6 HELIX 8 8 SER A 205 LEU A 221 1 17 HELIX 9 9 VAL A 231 HIS A 233 5 3 HELIX 10 10 PHE A 236 LYS A 250 1 15 HELIX 11 11 PRO A 267 GLU A 275 1 9 HELIX 12 12 PHE A 283 PHE A 293 1 11 HELIX 13 13 MET A 300 ASP A 313 1 14 HELIX 14 14 VAL A 317 ASP A 319 5 3 HELIX 15 15 ARG A 339 THR A 351 1 13 HELIX 16 16 THR A 362 GLN A 364 5 3 HELIX 17 17 ASP A 373 ARG A 375 5 3 HELIX 18 18 THR A 386 CYS A 400 1 15 HELIX 19 19 PRO A 402 TYR A 406 1 5 HELIX 20 20 SER A 473 GLY A 475 5 3 HELIX 21 21 GLY A 538 ASP A 540 5 3 HELIX 22 22 SER A 611 LEU A 613 5 3 HELIX 23 23 PRO A 618 LYS A 620 5 3 SHEET 1 A 6 PRO A 356 TYR A 359 0 SHEET 2 A 6 VAL A 16 ILE A 20 1 N ILE A 17 O PRO A 356 SHEET 3 A 6 ALA A 73 ILE A 76 1 N ALA A 73 O TYR A 18 SHEET 4 A 6 LYS A 131 PHE A 136 1 N LYS A 131 O ILE A 74 SHEET 5 A 6 GLY A 225 MET A 228 1 N GLY A 225 O ILE A 134 SHEET 6 A 6 PHE A 253 GLY A 256 1 N PHE A 253 O ILE A 226 SHEET 1 B 2 ILE A 87 TYR A 89 0 SHEET 2 B 2 VAL A 92 ASN A 94 -1 N ASN A 94 O ILE A 87 SHEET 1 C 4 THR A 487 THR A 493 0 SHEET 2 C 4 ASN A 428 ASN A 435 -1 N ALA A 433 O ALA A 488 SHEET 3 C 4 VAL A 418 PHE A 425 -1 N PHE A 425 O ASN A 428 SHEET 4 C 4 SER A 408 ILE A 414 -1 N TRP A 413 O ILE A 420 SHEET 1 D 2 ALA A 442 ILE A 444 0 SHEET 2 D 2 PHE A 480 LEU A 482 -1 N LEU A 482 O ALA A 442 SHEET 1 E 2 GLY A 454 TYR A 456 0 SHEET 2 E 2 LEU A 469 VAL A 471 -1 N VAL A 471 O GLY A 454 SHEET 1 F 3 MET A 508 LYS A 510 0 SHEET 2 F 3 PHE A 579 LEU A 582 1 N GLU A 580 O ALA A 509 SHEET 3 F 3 GLY A 559 TYR A 561 -1 N TYR A 561 O PHE A 579 SHEET 1 G 4 THR A 500 GLY A 505 0 SHEET 2 G 4 THR A 514 ARG A 520 -1 N ARG A 520 O THR A 500 SHEET 3 G 4 GLN A 548 LYS A 552 -1 N VAL A 551 O ILE A 515 SHEET 4 G 4 ILE A 541 GLU A 545 -1 N GLU A 545 O GLN A 548 SHEET 1 H 3 ILE A 563 ALA A 566 0 SHEET 2 H 3 THR A 528 PHE A 531 -1 N TYR A 530 O LYS A 564 SHEET 3 H 3 THR A 534 VAL A 536 -1 N VAL A 536 O VAL A 529 SHEET 1 I 3 TRP A 636 PRO A 643 0 SHEET 2 I 3 GLN A 586 ASN A 594 -1 N VAL A 593 O TRP A 636 SHEET 3 I 3 ALA A 678 ASN A 683 1 N ALA A 678 O ARG A 590 SHEET 1 J 3 ASN A 603 GLY A 608 0 SHEET 2 J 3 THR A 647 LYS A 655 -1 N LYS A 655 O ASN A 603 SHEET 3 J 3 HIS A 668 THR A 671 -1 N PHE A 670 O ILE A 648 SHEET 1 K 2 LEU A 653 GLN A 656 0 SHEET 2 K 2 THR A 659 TRP A 662 -1 N THR A 661 O LYS A 654 SHEET 1 L 2 LEU A 157 ASP A 159 0 SHEET 2 L 2 THR A 162 GLY A 165 -1 N GLY A 165 O LEU A 157 SSBOND 1 CYS A 43 CYS A 50 1555 1555 2.03 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.41 LINK O4 GLC B 2 C1 GLC B 3 1555 1555 1.39 LINK O4 GLC B 3 C1 GLC B 4 1555 1555 1.43 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.41 LINK O4 GLC D 1 C1 GLC D 2 1555 1555 1.41 LINK O4 GLC E 1 C1 GLC E 2 1555 1555 1.40 LINK OD1 ASP A 27 CA CA A 689 1555 1555 2.36 LINK O ASN A 29 CA CA A 689 1555 1555 2.54 LINK OD1 ASN A 32 CA CA A 689 1555 1555 2.39 LINK OD1 ASN A 33 CA CA A 689 1555 1555 2.22 LINK O GLY A 51 CA CA A 689 1555 1555 2.56 LINK OD2 ASP A 53 CA CA A 689 1555 1555 2.38 LINK OD1 ASN A 139 CA CA A 690 1555 1555 2.34 LINK O ILE A 190 CA CA A 690 1555 1555 2.65 LINK OD1 ASP A 199 CA CA A 690 1555 1555 2.53 LINK OD2 ASP A 199 CA CA A 690 1555 1555 2.59 LINK O HIS A 233 CA CA A 690 1555 1555 2.46 LINK CA CA A 689 O HOH A 780 1555 1555 2.59 LINK CA CA A 690 O HOH A 698 1555 1555 2.49 LINK CA CA A 690 O HOH A 709 1555 1555 2.61 CISPEP 1 ASP A 371 PRO A 372 0 4.84 CISPEP 2 GLY A 505 PRO A 506 0 -2.50 CISPEP 3 GLY A 623 PRO A 624 0 1.59 CISPEP 4 TYR A 633 PRO A 634 0 5.23 SITE 1 CAT 3 ASP A 229 GLU A 257 ASP A 328 SITE 1 CA1 6 ASP A 27 ASN A 29 ASN A 32 ASN A 33 SITE 2 CA1 6 GLY A 51 ASP A 53 SITE 1 CA2 4 ASN A 139 ILE A 190 ASP A 199 HIS A 233 SITE 1 16 6 SER A 382 TRP A 616 LYS A 651 TRP A 662 SITE 2 16 6 GLU A 663 ASN A 667 SITE 1 26 7 THR A 598 ALA A 599 GLY A 601 ASN A 603 SITE 2 26 7 ASN A 627 GLN A 628 TYR A 633 SITE 1 36 10 TYR A 301 GLU A 411 ARG A 412 TRP A 413 SITE 2 36 10 ILE A 414 GLY A 446 VAL A 448 SER A 537 SITE 3 36 10 ALA A 539 ASP A 540 CRYST1 121.388 111.604 66.386 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008238 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008960 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015063 0.00000